FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

17873711000001100: Lodotra 2mg modified-release tablets (Napp Pharmaceuticals Ltd) 100 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Oct 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
62099801000001110 Lodotra 2mg modified-release tablets (Napp Pharmaceuticals Ltd) 100 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
62099901000001116 Lodotra 2mg modified-release tablets (Napp Pharmaceuticals Ltd) 100 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lodotra 2mg modified-release tablets (Napp Pharmaceuticals Ltd) 100 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lodotra 2mg modified-release tablets (Napp Pharmaceuticals Ltd) 100 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lodotra 2mg modified-release tablets (Napp Pharmaceuticals Ltd) 100 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Lodotra 2mg modified-release tablets (Napp Pharmaceuticals Ltd) 100 tablet Is a Prednisone 2mg modified-release tablets 100 tablet true Inferred relationship Existential restriction modifier
Lodotra 2mg modified-release tablets (Napp Pharmaceuticals Ltd) 100 tablet Has AMP Lodotra 2mg modified-release tablets (Napp Pharmaceuticals Ltd) true Inferred relationship Existential restriction modifier
Lodotra 2mg modified-release tablets (Napp Pharmaceuticals Ltd) 100 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Lodotra 2mg modified-release tablets (Napp Pharmaceuticals Ltd) 100 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lodotra 2mg modified-release tablets (Napp Pharmaceuticals Ltd) 100 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Lodotra 2mg modified-release tablets (Napp Pharmaceuticals Ltd) 100 tablet Has specific active ingredient Prednisone true Inferred relationship Existential restriction modifier
Lodotra 2mg modified-release tablets (Napp Pharmaceuticals Ltd) 100 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Lodotra 2mg modified-release tablets (Napp Pharmaceuticals Ltd) 100 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Lodotra 2mg modified-release tablets (Napp Pharmaceuticals Ltd) 100 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Lodotra 2mg modified-release tablets (Napp Pharmaceuticals Ltd) 100 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Lodotra 2mg modified-release tablets (Napp Pharmaceuticals Ltd) 100 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Lodotra 2mg modified-release tablets (Napp Pharmaceuticals Ltd) 100 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start